Antibiotic Treatment Versus no Therapy in Kidney Transplant Recipients With Asymptomatic Bacteriuria
NCT01771432 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2015-06-22
Summary
Objective: To determine whether antibiotic treatment of asymptomatic bacteriuria in kidney transplant recipients could be useful to prevent pyelonephritis in these patients.
Conditions
- Asymptomatic Bacteriuria
- Pyelonephritis
Interventions
- DRUG
-
Antibiotic treatment
Kidney transplant recipients with asymptomatic bacteriuria will be treated with antibiotics
- OTHER
-
No treatment
Kidney transplant recipients with asymptomatic bacteriuria will be followed without antibiotic therapy
Sponsors & Collaborators
-
Núria Sabé Fernàndez
lead OTHER
Principal Investigators
-
Núria Sabé Fernàndez · Hospital Universitari de Bellvitge
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-12-31
Countries
- Spain
Study Locations
More Related Trials
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
NCT02852902 ·Status: COMPLETED
-
Antibiotic Prophylaxis in Lung-Transplant Recipients
NCT06760143 ·Status: COMPLETED
-
Clinical Significance and Optimal Treatment of Community-onset Urinary Tract Infections Caused by Extended-spectrum β-lactamase and/or AmpC β-lactamase Producing Enterobacteriaceae
NCT01138566 ·Status: UNKNOWN
-
An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.
NCT01173068 ·Status: UNKNOWN
-
A Prospective Observational Study of Patients With Drug Resistant Acinetobacter Baumannii Bacteremia
NCT01511224 ·Status: UNKNOWN
-
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
NCT06910878 ·Status: RECRUITING
-
Selective Reporting for Antibiotic Susceptibility Testing and GPs' Prescribing of Broad-spectrum Antibiotics in Women With E. Coli UTIs
NCT06067386 ·Status: UNKNOWN ·Phase: NA
-
Study of the Impact of the Minimum Inhibitory Concentration and Susceptible Cut-off Points (CLSI, EUCAST, and Pharmacokinetics/Pharmacodynamics)in Prognosis of Bacteremia by Enterobacteriaceae
NCT02005159 ·Status: COMPLETED
-
A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)
NCT00379951 ·Status: COMPLETED ·Phase: PHASE3
-
Emergence of Gram-negative Resistance in Blood Culture Isolates of Solid-organ Transplant Recipients
NCT00304330 ·Status: COMPLETED
-
Impact of a TDM-guided ECPA Program for Optimizing Pharmacodynamic Target Attainment of Continuous Infusion Beta-lactam-based Regimen
NCT06718517 ·Status: RECRUITING
-
Optimization Management Study of Community Urinary Tract Infections Spectrum
NCT03655548 ·Status: COMPLETED
-
Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae
NCT02795949 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Extended Spectrum Betalactamase Producing Bacteria Causing Urinary Tract Infections in General Practice
NCT01531023 ·Status: COMPLETED
-
Qnr Genes in Enterobacteriaceae
NCT02834910 ·Status: COMPLETED
-
Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics
NCT02717273 ·Status: COMPLETED ·Phase: PHASE3
-
Antibiotic Therapy Versus Appendectomy for Acute Appendicitis
NCT00135603 ·Status: COMPLETED ·Phase: NA
-
Opportunities for Antibiotic Optimisation and Outcomes Improvement in Patients With Negative Blood Culture (NO-BACT)
NCT03535324 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares
NCT00976638 ·Status: COMPLETED ·Phase: NA
-
Ertapenem in Patients With Urosepsis
NCT03859362 ·Status: UNKNOWN ·Phase: PHASE4
-
A Digital Antimicrobial Stewardship Smartphone Application to Combat AMR: the AB-assistant
NCT03793946 ·Status: UNKNOWN ·Phase: NA
-
Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to Extended-spectrum Beta-lactamase (ESBL) or Carbapenemase-producing Enterobacteriaceae: an Observational Multinational Study
NCT01764490 ·Status: COMPLETED
-
Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP
NCT02364284 ·Status: COMPLETED
-
Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients
NCT00235664 ·Status: COMPLETED
-
Prophylaxis With Single Versus Five Dose of Antibiotic Therapy as Treatment of Patients With Gangrenous Acute Appendicitis
NCT01115153 ·Status: COMPLETED ·Phase: NA